| [1] |
中华医学会妇产科学分会产科学组，中华医学会围产医学分会. 产后出血预防与处理指南(2023)[J]. 中华妇产科杂志，2023，58(6)：401-409.
|
| [2] |
Borovac-Pinheiro A, Pacagnella RC, Cecatti JG, et al. Postpartum hemorrhage: new insights for definition and diagnosis[J]. Am J Obstet Gynecol，2018，219(2)：162-168.
|
| [3] |
Thompson JF, Ford JB, Raynes-Greenow CH, et al. Women′s experiences of care and their concerns and needs following a significant primary postpartum hemorrhage[J]. Birth，2011，38(4)：327-335.
|
| [4] |
Leduc D, Senikas V, Lalonde AB, et al. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage[J]. J Obstet Gynaecol Can，2009，31(10)：980-993.
|
| [5] |
Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990－2019: update from the GBD 2019 study[J]. J Am Coll Cardiol，2020，76(25)：2982-3021.
|
| [6] |
Cai X, Song S, Hu J, et al. Association of the trajectory of plasma aldosterone concentration with the risk of cardiovascular disease in patients with hypertension: a cohort study[J]. Sci Rep，2024，14(1)：4906.
|
| [7] |
梁双依，曲江雪，石慧峰，等. 产后出血量与孕产妇不良临床结局的相关性研究[J]. 中华妇产科杂志，2025，60(6)：422-429.
|
| [8] |
Johnston A, Smith GN, Tanuseputro P, et al. Assessing cardiovascular disease risk in women with a history of hypertensive disorders of pregnancy: a guidance paper for studies using administrative data[J]. Paediatr Perinat Epidemiol，2024，38(3)：254-267.
|
| [9] |
Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis[J]. Diabetologia，2019，62(6)：905-914.
|
| [10] |
Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease commission: reducing the global burden by 2030[J]. Lancet，2021，397(10292)：2385-2438.
|
| [11] |
Cho GJ, Lee K, Kim HY, et al. Postpartum haemorrhage requiring transfusion and risk of cardiovascular disease later in life: a retrospective cohort study[J]. BJOG，2021，128(4)：738-744.
|
| [12] |
Yang S, Liu Y, Zhou Z, et al. A case report of uterine necrosis following cesarean section: lessons learned from cross binding suture for refractory postpartum hemorrhage[J]. Front Med (Lausanne)，2025，12：1568361.
|
| [13] |
Chauleur C, Cochery-Nouvellon E, Mercier E, et al. Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort[J]. Thromb Haemost，2008，100(5)：773-779.
|
| [14] |
Al-Nuaim LA, Mustafa MS, Gader AGMA. Disseminated intravascular coagulation and massive obstetric hemorrhage. Management dilemma[J]. Saudi Med J，2002，23(6)：658-662.
|
| [15] |
竺洁，熊钰. 严重产后出血与凝血功能障碍[J/OL]. 中华产科急救电子杂志，2025，14(3)：133-138.
|
| [16] |
Thurn L, Wikman A, Lindqvist PG. Postpartum blood transfusion and hemorrhage as independent risk factors for venous thromboembolism[J]. Thromb Res，2018，165：54-60.
|
| [17] |
Brown HL, Warner JJ, Gianos E, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists[J]. Circulation，2018，137(24)：e843-852.
|
| [18] |
周玮. 严重产后出血的早识别[J/OL]. 中华产科急救电子杂志，2025，14(2): 70-74.
|
| [19] |
Azulay CE, Pariente G, Shoham-Vardi I, et al. Maternal anemia during pregnancy and subsequent risk for cardiovascular disease[J]. J Matern Fetal Neonatal Med，2015，28(15)：1762-1765.
|
| [20] |
Auger N, Potter BJ, He S, et al. Maternal cardiovascular disease 3 decades after preterm birth: longitudinal cohort study of pregnancy vascular disorders[J]. Hypertension，2020，75(3)：788-795.
|
| [21] |
Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association[J]. Circulation，2021，143(18)：e902-916.
|
| [22] |
Moens AL, Claeys MJ, Timmermans JP, et al. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process[J]. Int J Cardiol，2005，100(2)：179-190.
|
| [23] |
Tan L, She H, Wang Y, et al. The new nano-resuscitation solution (TPP-MR) attenuated myocardial injury in hemorrhagic shock rats by inhibiting ferroptosis[J]. Int J Nanomedicine，2024，19：7567-7583.
|
| [24] |
Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease[J]. N Engl J Med，2017，377(12)：1119-1131.
|
| [25] |
Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target[J]. J Clin Invest，2013，123(1)：92-100.
|
| [26] |
Rajendran P, Rengarajan T, Thangavel J, et al. The vascular endothelium and human diseases[J]. Int J Biol Sci，2013，9(10)：1057-1069.
|
| [27] |
Sultan AA, Grainge MJ, West J, et al. Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England[J]. Blood，2014，124(18)：2872-2880.
|
| [28] |
Sheehan HL. Post-partum necrosis of the anterior pituitary[J]. Trans Edinb Obstet Soc，1938，58：13-28.
|
| [29] |
Karaca Z, Laway BA, Dokmetas HS, et al. Sheehan syndrome[J]. Nat Rev Dis Primers，2016，2：16092.
|
| [30] |
Laway BA, Baba MS. Sheehan syndrome: cardiovascular and metabolic comorbidities[J]. Front Endocrinol (Lausanne)，2023，14：1086731.
|
| [31] |
Filipsson H, Monson JP, Koltowska-Häggström M, et al. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients[J]. J Clin Endocrinol Metab，2006，91(10)：3954-3961.
|
| [32] |
Bhat MA, Laway BA, Shah ZA, et al. Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan′s syndrome on standard replacement therapy: a case control study[J]. Pituitary，2015，18(3)：312-318.
|
| [33] |
Das L, Sahoo J, Dahiya N, et al. Long-term hepatic and cardiac health in patients diagnosed with Sheehan′s syndrome[J]. Pituitary，2022，25(6)：971-981.
|
| [34] |
Latt SM, Opondo C, Alderdice F, et al. Postpartum haemorrhage and risk of cardiovascular disease in later life: a population-based record linkage cohort study[J]. BJOG，2024，131(12)：1705-1714.
|
| [35] |
Ukah UV, Platt RW, Potter BJ, et al. Obstetric haemorrhage and risk of cardiovascular disease after three decades: a population-based cohort study[J]. BJOG，2020，127(12)：1489-1497.
|
| [36] |
Parry-Smith W, Šumilo D, Subramanian A, et al. Postpartum haemorrhage and risk of long-term hypertension and cardiovascular disease: an English population-based longitudinal study using linked primary and secondary care databases[J]. BMJ Open，2021，11(5)：e041566.
|
| [37] |
Aimagambetova G, Bapayeva G, Sakhipova G, et al. Management of postpartum hemorrhage in low- and middle-income countries: emergency need for updated approach due to specific circumstances, resources, and availabilities[J]. J Clin Med，2024，13(23)：7387.
|
| [38] |
中华医学会心血管病学分会，中华心血管病杂志编辑委员会. 妊娠期高血压疾病心血管风险综合管理专家共识[J]. 中华心血管病杂志，2025(3)：235-246.
|
| [39] |
中国心血管病风险评估和管理指南编写联合委员会. 中国心血管病风险评估和管理指南[J]. 中华预防医学杂志，2019，53(1)：13-35.
|
| [40] |
Latt SM, Alderdice F, Elkington M, et al. Primary postpartum haemorrhage and longer-term physical, psychological, and psychosocial health outcomes for women and their partners in high income countries: a mixed-methods systematic review[J]. PLoS One，2023，18(6)：e0274041.
|